Univest
Univest
  • Markets

3 City Gas Distributor, Banking Software Products Company and Diagnostics Company Stocks With a Strong Future Roadmap: Adani Total Gas, Nucleus Software Exports and Thyrocare Technologies

  • November 16, 2026
  • Posted by: Kunal Singla
  • Category: Best Stocks
No Comments
3 City Gas Distributor, Banking Software Products Company and Diagnostics Company Stocks With a Strong Future Roadmap: Adani Total Gas, Nucleus Software Exports and Thyrocare Technologies

Adani Total Gas, Nucleus Software Exports and Thyrocare Technologies: ROE of 12.4% to 27.9% and FY22 to FY26 revenue CAGR of 8.2% to 17.8%. Prices as of 13 Nov 2026.

Quick Answer

The three city gas, banking software and lab stocks to watch are Adani Total Gas, Nucleus Software Exports and Thyrocare Technologies. Their return on equity ranges from 12.4% to 27.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.2% to 17.8%. Thyrocare Technologies has the highest return on equity at 27.9%, while Adani Total Gas has the fastest revenue growth at 17.8% a year. Prices are based on the 13 November 2026 close, and this article is educational, not investment advice.

City gas, banking software and lab stocks let investors follow companies that serve a growing part of the Indian economy. Adani Total Gas, Nucleus Software Exports and Thyrocare Technologies cover a city gas distributor, a banking software products company and a diagnostics company.

This list covers three city gas, banking software and lab stocks with complete current figures: Adani Total Gas, Nucleus Software Exports and Thyrocare Technologies. Every figure comes from the latest reported financials and the 13 November 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • What Are City Gas, Banking Software and Lab Stocks?
  • City Gas, Banking Software and Lab Stocks at a Glance
  • Why Do City Gas, Banking Software and Lab Stocks Have a Strong Roadmap in India?
  • Why Adani Total Gas Features Among These City Gas, Banking Software and Lab Stocks
  • Why Nucleus Software Exports Features Among These City Gas, Banking Software and Lab Stocks
  • Why Thyrocare Technologies Features Among These City Gas, Banking Software and Lab Stocks
  • Adani Total Gas vs Nucleus Software Exports vs Thyrocare Technologies on Key Financials
  • Key Risks to Check Before Investing in City Gas, Banking Software and Lab Stocks
  • Final Thoughts on City Gas, Banking Software and Lab Stocks
    • What are city gas, banking software and lab stocks?
    • Which city gas, banking software and lab stocks are covered in this list?
    • Why do city gas, banking software and lab stocks have a strong future roadmap in India?
    • How has Adani Total Gas performed financially?
    • How has Nucleus Software Exports performed financially?
    • How has Thyrocare Technologies performed financially?
    • What risks should investors check before buying city gas, banking software and lab stocks?
    • Is this list of city gas, banking software and lab stocks investment advice?

What Are City Gas, Banking Software and Lab Stocks?

City gas, banking software and lab stocks are listed companies that supply piped gas to homes and CNG to vehicles, build software products for banks and lenders, and run diagnostic labs and collection centres. Their earnings depend on gas volumes, technology spending and test volumes.

City Gas, Banking Software and Lab Stocks at a Glance

Company CMP (Rs) Market Cap (Rs Cr) P/E Industry P/E ROE (%) D/E
Adani Total Gas 575.4 58,229 90.7 13.8 12.4 0.47
Nucleus Software Exports 624.8 1,731 16.4 17.5 14.7 0.01
Thyrocare Technologies 498.25 7,501 42.6 59.6 27.9 0.09

On valuation, Nucleus Software Exports and Thyrocare Technologies trade at a P/E below the industry P/E, while Adani Total Gas trades above it, which reflects the growth the market already expects. Readers comparing city gas, banking software and lab stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in city gas, banking software and lab stocks can use the coming numbers to test whether growth is holding.

Why Do City Gas, Banking Software and Lab Stocks Have a Strong Roadmap in India?

City gas, banking software and lab stocks have a strong roadmap in India because a wider switch to cleaner gas, rising digital investment by financial firms and wider use of preventive tests keep widening the market for these companies.

  • City gas. Homes and vehicles shift to cleaner fuel.
  • Banking software. Financial firms modernise their systems.
  • Diagnostics. Families test more for preventive care.

Why Adani Total Gas Features Among These City Gas, Banking Software and Lab Stocks

Among the city gas, banking software and lab stocks on this list, Adani Total Gas is a city gas distribution company that supplies piped natural gas to homes, industries and commercial users and compressed natural gas to vehicles across many cities, and it also sets up electric vehicle charging points.

The company has a return on equity of 12.4%, a debt to equity ratio of 0.47 and a market capitalisation of Rs 58,229 crore. The stock trades at a P/E of 90.7, above the industry P/E of 13.8.

Revenue rose from Rs 3,079 crore in FY22 to Rs 5,932 crore in FY26, a compound annual growth rate of 17.8%. Net profit grew from Rs 505 crore in FY22 to Rs 656 crore in FY26, which works out to a compound annual growth rate of 6.8%.

Roadmap: The company is extending its pipeline network and CNG station base into the cities it has been awarded, which widens its customer base. Rising use of cleaner fuel in households and vehicles supports volume growth.

What to watch: Track new city additions, CNG volumes and progress in electric vehicle charging.

Why Nucleus Software Exports Features Among These City Gas, Banking Software and Lab Stocks

Among the piped gas, bank technology and pathology shares on this list, Nucleus Software Exports is a Noida-based software products company that builds lending and transaction banking software, with its FinnAxia and FinnOne platforms used by banks and financial institutions in India and overseas.

Revenue rose from Rs 532 crore in FY22 to Rs 940 crore in FY26, a compound annual growth rate of 15.3%. Net profit grew from Rs 40.9 crore in FY22 to Rs 117 crore in FY26, which works out to a compound annual growth rate of 30.0%.

The company has a return on equity of 14.7%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 1,731 crore. The stock trades at a P/E of 16.4, below the industry P/E of 17.5.

Roadmap: The company is moving customers to cloud-based and subscription offerings, which build recurring revenue over time. Banks upgrading lending and transaction systems create steady demand for its platforms.

What to watch: Monitor licence and subscription revenue and the pace of new customer wins.

Why Thyrocare Technologies Features Among These City Gas, Banking Software and Lab Stocks

Among the three companies on this list, Thyrocare Technologies runs a centralised, high-volume testing laboratory in Navi Mumbai and collects samples through a wide partner network of diagnostic centres, pharmacies and franchisees across India.

In the June 2026 quarter, revenue grew 23.5% year on year to Rs 244 crore, while net profit rose 34.1% to Rs 51.3 crore. Revenue rose from Rs 618 crore in FY22 to Rs 846 crore in FY26, a compound annual growth rate of 8.2%.

Net profit grew from Rs 64.4 crore in FY23 to Rs 163 crore in FY26, which works out to a compound annual growth rate of 36.3%. The company has a return on equity of 27.9%, a debt to equity ratio of 0.09 and a market capitalisation of Rs 7,501 crore. The stock trades at a P/E of 42.6, below the industry P/E of 59.6.

Roadmap: The centralised model gives it a low unit cost per test, and the company is adding wellness and preventive health packages along with a growing share of direct-to-consumer bookings. Its partner-led channel lets it scale volumes without building its own collection centres.

What to watch: Track growth in test volume per day and the share of revenue from preventive health packages.

Adani Total Gas vs Nucleus Software Exports vs Thyrocare Technologies on Key Financials

The table below sets the three city gas, banking software and lab stocks side by side on revenue, profit and margin, using reported figures.

Company FY22 Revenue (Rs Cr) FY26 Revenue (Rs Cr) Revenue CAGR (FY22-FY26) FY26 Net Profit (Rs Cr) FY26 Net Margin
Adani Total Gas 3,079 5,932 17.8% 656 11.1%
Nucleus Software Exports 532 940 15.3% 117 12.4%
Thyrocare Technologies 618 846 8.2% 163 19.2%

Thyrocare Technologies posts the highest return on equity in this group at 27.9%. Adani Total Gas combines the largest FY26 revenue at Rs 5,932 crore with the fastest revenue growth, a 17.8% compound annual rate. A useful habit with city gas, banking software and lab stocks is to check each new quarterly result against the capacity plans the company described earlier.

Key Risks to Check Before Investing in City Gas, Banking Software and Lab Stocks

Every theme carries risks that deserve a check before any decision. For these city gas, banking software and lab stocks, the main points are: Long-term piped gas, bank technology and pathology shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.

  • Gas prices and rules. Gas costs and regulated tariffs can influence earnings.
  • Client spending. Technology budgets can vary with global conditions.
  • Capacity ramp up. New hospitals take time to fill beds and reach full returns.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter city gas, banking software and lab stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on City Gas, Banking Software and Lab Stocks

City gas, banking software and lab stocks reward investors who follow demand trends, order books and margins together. Adani Total Gas, Nucleus Software Exports and Thyrocare Technologies each have a clear plan to grow. Based on the 13 November 2026 close, Adani Total Gas trades at Rs 575.4, Nucleus Software Exports at Rs 624.8 and Thyrocare Technologies at Rs 498.25. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these city gas, banking software and lab stocks to a watchlist.

Download the Univest iOS App or Univest Android App to track city gas, banking software and lab stocks, set price alerts and get research-backed stock ideas.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

What are city gas, banking software and lab stocks?

Ans. City gas, banking software and lab stocks are listed companies that supply piped gas to homes and CNG to vehicles, build software products for banks and lenders, and run diagnostic labs and collection centres. Their earnings depend on gas volumes, technology spending and test volumes. This list looks at three of them, Adani Total Gas, Nucleus Software Exports and Thyrocare Technologies, using reported FY22 to FY26 financials and the 13 November 2026 closing prices.

Which city gas, banking software and lab stocks are covered in this list?

Ans. This list covers Adani Total Gas, Nucleus Software Exports and Thyrocare Technologies. Based on the 13 November 2026 close, Adani Total Gas traded at Rs 575.4, Nucleus Software Exports at Rs 624.8 and Thyrocare Technologies at Rs 498.25. Their return on equity ranges from 12.4% to 27.9%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.2% to 17.8%.

Why do city gas, banking software and lab stocks have a strong future roadmap in India?

Ans. City gas, banking software and lab stocks have a strong roadmap in India because a wider switch to cleaner gas, rising digital investment by financial firms and wider use of preventive tests keep widening the market for these companies. The main drivers are as follows. City gas. Homes and vehicles shift to cleaner fuel. Banking software. Financial firms modernise their systems. Diagnostics. Families test more for preventive care. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Adani Total Gas performed financially?

Ans. Revenue rose from Rs 3,079 crore in FY22 to Rs 5,932 crore in FY26, a compound annual growth rate of 17.8%. Net profit grew from Rs 505 crore in FY22 to Rs 656 crore in FY26, which works out to a compound annual growth rate of 6.8%. The company has a return on equity of 12.4%, a debt to equity ratio of 0.47 and a market capitalisation of Rs 58,229 crore. The stock trades at a P/E of 90.7, above the industry P/E of 13.8. Looking ahead, the company is extending its pipeline network and CNG station base into the cities it has been awarded, which widens its customer base. Rising use of cleaner fuel in households and vehicles supports volume growth.

How has Nucleus Software Exports performed financially?

Ans. Revenue rose from Rs 532 crore in FY22 to Rs 940 crore in FY26, a compound annual growth rate of 15.3%. Net profit grew from Rs 40.9 crore in FY22 to Rs 117 crore in FY26, which works out to a compound annual growth rate of 30.0%. The company has a return on equity of 14.7%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 1,731 crore. The stock trades at a P/E of 16.4, below the industry P/E of 17.5. Looking ahead, the company is moving customers to cloud-based and subscription offerings, which build recurring revenue over time. Banks upgrading lending and transaction systems create steady demand for its platforms.

How has Thyrocare Technologies performed financially?

Ans. Revenue rose from Rs 618 crore in FY22 to Rs 846 crore in FY26, a compound annual growth rate of 8.2%. Net profit grew from Rs 64.4 crore in FY23 to Rs 163 crore in FY26, which works out to a compound annual growth rate of 36.3%. In the June 2026 quarter, revenue grew 23.5% year on year to Rs 244 crore, while net profit rose 34.1% to Rs 51.3 crore. The company has a return on equity of 27.9%, a debt to equity ratio of 0.09 and a market capitalisation of Rs 7,501 crore. The stock trades at a P/E of 42.6, below the industry P/E of 59.6. Looking ahead, the centralised model gives it a low unit cost per test, and the company is adding wellness and preventive health packages along with a growing share of direct-to-consumer bookings. Its partner-led channel lets it scale volumes without building its own collection centres.

What risks should investors check before buying city gas, banking software and lab stocks?

Ans. Investors should check a few risks before buying city gas, banking software and lab stocks. Gas prices and rules. Gas costs and regulated tariffs can influence earnings. Client spending. Technology budgets can vary with global conditions. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of city gas, banking software and lab stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 13 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.



adani total gas bank technology and pathology shares banking software and lab stocks Best Stocks city gas fintech products and health test stocks Gas Distribution Nucleus Software Exports piped gas Thyrocare Technologies
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply